May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Activation of Erk by Endothelin–1 Induced Neurotoxicity in the Rat Retina
Author Affiliations & Notes
  • Y. Munemasa
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Ophthalmology,
  • Y. Kitaoka
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Ophthalmology,
  • R. Ohtani–Kaneko
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Anatomy and Cell Biology,
  • Y. Hayashi
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Ophthalmology,
  • K. Kuribayashi
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Ophthalmology,
  • J. Kogo
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Pharmacology,
  • H. Takeda
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Ophthalmology,
  • K. Hirata
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Anatomy and Cell Biology,
  • S. Ueno
    St.Marianna University School of Medicine, Kawasaki–shi, Japan
    Ophthalmology,
  • Footnotes
    Commercial Relationships  Y. Munemasa, None; Y. Kitaoka, None; R. Ohtani–Kaneko, None; Y. Hayashi, None; K. Kuribayashi, None; J. Kogo, None; H. Takeda, None; K. Hirata, None; S. Ueno, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2057. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Munemasa, Y. Kitaoka, R. Ohtani–Kaneko, Y. Hayashi, K. Kuribayashi, J. Kogo, H. Takeda, K. Hirata, S. Ueno; Activation of Erk by Endothelin–1 Induced Neurotoxicity in the Rat Retina . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2057.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Endothelin–1 (ET–1) is a potent vasoconstrictor peptide produced by vascular endothelial cells. Previous reports have shown that intravitreal injection of ET–1 induced optic nerve head (ONH) ischemia. However, the detail mechanism of ET–1–induced neuronal damage is unclear. In this study, we examined the expression of phosphorylated ERK (p–ERK) in ET–1–induced neurotoxicity in the rat retina and optic nerve.

Methods: : Two micro liter of 0.1 mM (total amount of 0.2 nmol) ET–1 was injected intravitreally into the eye. Activation of ERK was examined by Western blot analysis and its localization was detected by immunohistochemistry. Axonal degeneration of optic nerve was evaluated by Western blot analysis for neurofilament (NF) and phosphorylated neurofilament (p–NF) 7, 14, 21 and 28 days after the injection. Cell count of the RGCL and measurement of the IPL thickness were performed by HE staining of the retinal transverse sections 14 and 28 days after the injection.

Results: : Western blot analysis showed the increase of p–ERK in the retina and the optic nerve 1 day after the injection. Immunoreactivity of p–ERK was detected in the glial cells in the retina and optic nerve head. The significant decreases of NF and p–NF protein in the optic nerve appeared from 28 days after the injection. Reduction of cells in the RGCL was also observed 28 days after the injection, while, IPL thickness did not change.

Conclusions: : ET–1 caused axonal degeneration and retinal neuronal cells death 28 days after the injection. The increase of p–ERK in the optic nerve and the retina may be involved in these processes.

Keywords: retina • optic disc • retinal degenerations: cell biology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×